Petia Mitchell

AMG 479, a fully human anti–insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells

Pedro J. Beltran, Petia Mitchell, Young-A Chung et al. · Molecular Cancer Therapeutics · 2009 · 131 citations · Full text

Medicine, Oncology, Pharmacology +14

Local Delivery of OncoVEXmGM-CSF Generates Systemic Antitumor Immune Responses Enhanced by Cytotoxic T-Lymphocyte–Associated Protein Blockade

Achim K. Moesta, Keegan S. Cooke, Julia Piasecki et al. · Clinical Cancer Research · 2017 · 105 citations

Life Sciences, Immunology, Oncology +17

Discovery of 1<i>H</i>-Pyrazol-3(2<i>H</i>)-ones as Potent and Selective Inhibitors of Protein Kinase R-like Endoplasmic Reticulum Kinase (PERK)

Adrian L. Smith, Kristin L. Andrews, Holger Beckmann et al. · Journal of Medicinal Chemistry · 2015 · 84 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Efficacy of Ganitumab (AMG 479), Alone and in Combination with Rapamycin, in Ewing’s and Osteogenic Sarcoma Models

Pedro J. Beltran, Young-Ah Chung, Gordon Moody et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 78 citations

Medicine, Oncology, Pharmacology +17

Ganitumab (AMG 479) Inhibits IGF-II–Dependent Ovarian Cancer Growth and Potentiates Platinum-Based Chemotherapy

Pedro J. Beltran, Frank J. Calzone, Petia Mitchell et al. · Clinical Cancer Research · 2014 · 47 citations

Medicine, Oncology, Pharmacology +17